RxDoctor Payments DataLook up a doctor →

Arthur Topoulos, MD

Nuclear Cardiology · Philadelphia, PANPI 1952331944

Payments from drug & device makers

$168,701in general payments, 2019–2025

Across 519 payments — averaging $325.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$67K
  • Novo Nordisk AS$61K
  • Medtronic$25K
  • Shockwave Medical, Inc$5K
  • Bard Peripheral Vascular, Inc.$2K
  • Inari Medical, Inc.$1K
  • plus $7K from 21 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few nuclear cardiology providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$284,858
Medicare patients
1,185
Services billed
2,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear cardiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →